GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (STU:TEHN) » Definitions » Capex-to-Revenue

Avid Bioservices (STU:TEHN) Capex-to-Revenue : 0.13 (As of Jan. 2024)


View and export this data going back to . Start your Free Trial

What is Avid Bioservices Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Avid Bioservices's Capital Expenditure for the three months ended in Jan. 2024 was €-4.12 Mil. Its Revenue for the three months ended in Jan. 2024 was €31.04 Mil.

Hence, Avid Bioservices's Capex-to-Revenue for the three months ended in Jan. 2024 was 0.13.


Avid Bioservices Capex-to-Revenue Historical Data

The historical data trend for Avid Bioservices's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices Capex-to-Revenue Chart

Avid Bioservices Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.06 0.10 0.47 0.52

Avid Bioservices Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.63 0.38 0.29 0.13

Competitive Comparison of Avid Bioservices's Capex-to-Revenue

For the Biotechnology subindustry, Avid Bioservices's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avid Bioservices's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avid Bioservices's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Avid Bioservices's Capex-to-Revenue falls into.



Avid Bioservices Capex-to-Revenue Calculation

Avid Bioservices's Capex-to-Revenue for the fiscal year that ended in Apr. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-70.806) / 136.131
=0.52

Avid Bioservices's Capex-to-Revenue for the quarter that ended in Jan. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-4.12) / 31.042
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avid Bioservices  (STU:TEHN) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Avid Bioservices Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Avid Bioservices (STU:TEHN) Business Description

Traded in Other Exchanges
Address
14191 Myford Road, Tustin, CA, USA, 92780
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Avid Bioservices (STU:TEHN) Headlines

No Headlines